JP2021518443A5 - - Google Patents
Info
- Publication number
- JP2021518443A5 JP2021518443A5 JP2021500778A JP2021500778A JP2021518443A5 JP 2021518443 A5 JP2021518443 A5 JP 2021518443A5 JP 2021500778 A JP2021500778 A JP 2021500778A JP 2021500778 A JP2021500778 A JP 2021500778A JP 2021518443 A5 JP2021518443 A5 JP 2021518443A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- concentration
- phosphatidylserine lipid
- polypeptide
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022082176A JP7313091B2 (ja) | 2018-03-23 | 2022-05-19 | サポシンｃ薬学的組成物および癌を治療する方法 |
| JP2023109939A JP2023118847A (ja) | 2018-03-23 | 2023-07-04 | サポシンｃ薬学的組成物および癌を治療する方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862647058P | 2018-03-23 | 2018-03-23 | |
| US62/647,058 | 2018-03-23 | ||
| US201862678668P | 2018-05-31 | 2018-05-31 | |
| US62/678,668 | 2018-05-31 | ||
| PCT/US2018/059016 WO2019182650A1 (en) | 2018-03-23 | 2018-11-02 | Saposin c pharmaceutical compositions and methods of treating cancer |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022082176A Division JP7313091B2 (ja) | 2018-03-23 | 2022-05-19 | サポシンｃ薬学的組成物および癌を治療する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021518443A JP2021518443A (ja) | 2021-08-02 |
| JP2021518443A5 true JP2021518443A5 (https=) | 2022-03-14 |
| JP7081865B2 JP7081865B2 (ja) | 2022-06-07 |
Family
ID=64664378
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021500778A Active JP7081865B2 (ja) | 2018-03-23 | 2018-11-02 | サポシンｃ薬学的組成物および癌を治療する方法 |
| JP2022082176A Active JP7313091B2 (ja) | 2018-03-23 | 2022-05-19 | サポシンｃ薬学的組成物および癌を治療する方法 |
| JP2023109939A Pending JP2023118847A (ja) | 2018-03-23 | 2023-07-04 | サポシンｃ薬学的組成物および癌を治療する方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022082176A Active JP7313091B2 (ja) | 2018-03-23 | 2022-05-19 | サポシンｃ薬学的組成物および癌を治療する方法 |
| JP2023109939A Pending JP2023118847A (ja) | 2018-03-23 | 2023-07-04 | サポシンｃ薬学的組成物および癌を治療する方法 |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US10682411B2 (https=) |
| EP (2) | EP3768246B1 (https=) |
| JP (3) | JP7081865B2 (https=) |
| KR (2) | KR102370952B1 (https=) |
| CN (2) | CN111902133B (https=) |
| AU (1) | AU2018414543B2 (https=) |
| BR (1) | BR112020018334A2 (https=) |
| CA (1) | CA3094928A1 (https=) |
| ES (1) | ES2895180T3 (https=) |
| IL (1) | IL277313B (https=) |
| MX (1) | MX2020009829A (https=) |
| PL (1) | PL3768246T3 (https=) |
| PT (1) | PT3768246T (https=) |
| RU (1) | RU2767199C1 (https=) |
| SG (1) | SG11202007884UA (https=) |
| WO (1) | WO2019182650A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111902133B (zh) * | 2018-03-23 | 2022-04-15 | 百祥制药公司 | 皂化蛋白c药物组合物和治疗癌症的方法 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4162282A (en) | 1976-04-22 | 1979-07-24 | Coulter Electronics, Inc. | Method for producing uniform particles |
| US4310505A (en) | 1979-11-08 | 1982-01-12 | California Institute Of Technology | Lipid vesicles bearing carbohydrate surfaces as lymphatic directed vehicles for therapeutic and diagnostic substances |
| US4533254A (en) | 1981-04-17 | 1985-08-06 | Biotechnology Development Corporation | Apparatus for forming emulsions |
| US4728575A (en) | 1984-04-27 | 1988-03-01 | Vestar, Inc. | Contrast agents for NMR imaging |
| US4921706A (en) | 1984-11-20 | 1990-05-01 | Massachusetts Institute Of Technology | Unilamellar lipid vesicles and method for their formation |
| US4857319A (en) * | 1985-01-11 | 1989-08-15 | The Regents Of The University Of California | Method for preserving liposomes |
| US4737323A (en) | 1986-02-13 | 1988-04-12 | Liposome Technology, Inc. | Liposome extrusion method |
| IL79559A0 (en) | 1986-07-29 | 1986-10-31 | Univ Ramot | Contrast agents for nmr medical imaging |
| US4728578A (en) | 1986-08-13 | 1988-03-01 | The Lubrizol Corporation | Compositions containing basic metal salts and/or non-Newtonian colloidal disperse systems and vinyl aromatic containing polymers |
| US5205290A (en) | 1991-04-05 | 1993-04-27 | Unger Evan C | Low density microspheres and their use as contrast agents for computed tomography |
| US6271196B1 (en) * | 1996-03-05 | 2001-08-07 | Regents Of The University Of Ca | Methods of alleviating neuropathic pain using prosaposin-derived peptides |
| US6872406B2 (en) | 2000-02-11 | 2005-03-29 | Children's Hospital Research Foundation | Fusogenic properties of saposin C and related proteins and polypeptides for application to transmembrane drug delivery systems |
| CN100366286C (zh) * | 2003-04-28 | 2008-02-06 | 常州南云科技有限公司 | Saposin C-DOPS:一种抗癌新药 |
| US7834147B2 (en) | 2003-04-28 | 2010-11-16 | Childrens Hospital Medical Center | Saposin C-DOPS: a novel anti-tumor agent |
| EP2020988B1 (en) * | 2006-04-28 | 2017-08-16 | Children's Hospital Medical Center | Compositions comprising fusogenic proteins or polypeptides derived from prosaposin for application in transmembrane drug delivery systems |
| CN101437485A (zh) | 2006-05-09 | 2009-05-20 | 高露洁-棕榄公司 | 口腔护理方案 |
| JP5253402B2 (ja) | 2006-10-20 | 2013-07-31 | チルドレンズ ホスピタル メディカル センター | 自発的に形成する楕円体の単層リン脂質小胞 |
| CN101209251A (zh) | 2006-12-28 | 2008-07-02 | 中国科学院理化技术研究所 | 含有紫杉醇或多烯紫杉醇的弹性纳米囊泡制剂及其制备方法 |
| WO2009049421A1 (en) * | 2007-10-18 | 2009-04-23 | The Hospital For Sick Children | Compositions and methods for enhancing enzyme activity in gaucher, gm1-gangliosidosis/morquio b disease, and parkinson's disease |
| WO2010053489A1 (en) * | 2008-11-07 | 2010-05-14 | Children's Hospital Medical Center | Fusogenic properties of saposin c and related proteins and peptides for application to transmembrane drug delivery systems |
| US7794969B1 (en) | 2009-07-09 | 2010-09-14 | Joule Unlimited, Inc. | Methods and compositions for the recombinant biosynthesis of n-alkanes |
| CN102614125B (zh) * | 2011-02-01 | 2018-11-02 | 常州长吉生物技术开发有限公司 | SapC-磷脂纳米囊泡冻干制剂、其制备方法及用途 |
| US20130247924A1 (en) | 2012-03-23 | 2013-09-26 | Mark Scatterday | Electronic cigarette having a flexible and soft configuration |
| CN104684546A (zh) * | 2012-06-07 | 2015-06-03 | 哈佛大学校长及研究员协会 | 用于药物靶向的纳米疗法 |
| US9757432B2 (en) | 2012-11-14 | 2017-09-12 | Ohio State Innovation Foundation | Materials and methods useful for treating glioblastorna |
| US10760112B2 (en) * | 2014-12-18 | 2020-09-01 | Shire Human Genetic Therapies, Inc. | Enzymatic activity assays for glucocerebrosidase |
| US9802942B2 (en) * | 2015-07-01 | 2017-10-31 | Northwestern University | Substituted 4-methyl-pyrrolo[1,2-A]pyrimidine-8-carboxamide compounds and uses thereof for modulating glucocerebrosidase activity |
| AU2017361541A1 (en) | 2016-11-21 | 2019-07-11 | Bexion Pharmaceuticals, Inc. | A combination therapy including SapC-DOPS for the treatment of pancreatic cancer |
| CN111902133B (zh) * | 2018-03-23 | 2022-04-15 | 百祥制药公司 | 皂化蛋白c药物组合物和治疗癌症的方法 |
-
2018
- 2018-11-02 CN CN201880091701.7A patent/CN111902133B/zh active Active
- 2018-11-02 SG SG11202007884UA patent/SG11202007884UA/en unknown
- 2018-11-02 PL PL18816295T patent/PL3768246T3/pl unknown
- 2018-11-02 MX MX2020009829A patent/MX2020009829A/es unknown
- 2018-11-02 AU AU2018414543A patent/AU2018414543B2/en active Active
- 2018-11-02 CA CA3094928A patent/CA3094928A1/en active Pending
- 2018-11-02 BR BR112020018334-2A patent/BR112020018334A2/pt unknown
- 2018-11-02 ES ES18816295T patent/ES2895180T3/es active Active
- 2018-11-02 US US16/179,139 patent/US10682411B2/en active Active
- 2018-11-02 CN CN202210300239.5A patent/CN114642720A/zh active Pending
- 2018-11-02 PT PT188162952T patent/PT3768246T/pt unknown
- 2018-11-02 WO PCT/US2018/059016 patent/WO2019182650A1/en not_active Ceased
- 2018-11-02 EP EP18816295.2A patent/EP3768246B1/en active Active
- 2018-11-02 RU RU2020134655A patent/RU2767199C1/ru active
- 2018-11-02 KR KR1020207030474A patent/KR102370952B1/ko active Active
- 2018-11-02 JP JP2021500778A patent/JP7081865B2/ja active Active
- 2018-11-02 KR KR1020227006894A patent/KR102483046B1/ko active Active
- 2018-11-02 EP EP21192293.5A patent/EP4005562A1/en active Pending
-
2020
- 2020-05-01 US US16/865,168 patent/US11590227B2/en active Active
- 2020-09-13 IL IL277313A patent/IL277313B/en active IP Right Grant
-
2022
- 2022-05-19 JP JP2022082176A patent/JP7313091B2/ja active Active
-
2023
- 2023-01-20 US US18/157,689 patent/US12194099B2/en active Active
- 2023-07-04 JP JP2023109939A patent/JP2023118847A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3993754A (en) | Liposome-encapsulated actinomycin for cancer chemotherapy | |
| TWI764943B (zh) | 一種抗pd-1抗體和vegfr抑制劑聯合在製備治療癌症的藥物中的用途 | |
| Shelly et al. | Model studies directed toward the boron neutron-capture therapy of cancer: boron delivery to murine tumors with liposomes. | |
| US7354579B2 (en) | Method of treating cancer with a VEGF antagonist and an anti-proliferative agent | |
| CA3009918C (en) | Method of treating a mammal, including human, against cancer using methionine and asparagine depletion | |
| WO2019200382A1 (en) | Nanoparticle compositions and methods of use of parp inhibitor for treatment of cancer | |
| JP2011516501A (ja) | 腫瘍疾患の治療 | |
| WO2007028341A1 (fr) | Nanomicelles servant de medicaments anticancereux a polyethylene phospholipides glycolyles contenant des vinca alcaloides | |
| ES2328822T3 (es) | Oligo-beta-(1,3)-glucano y anticuerpos monoclonales contra el cancer. | |
| CN112137958A (zh) | 一种含阿霉素与免疫佐剂组合药物脂质体及其制备方法 | |
| JP2003501379A (ja) | ガン治療のための薬剤を充填したナノパーティクルの使用 | |
| US10617672B2 (en) | Liposome composition co-encapsulating doxorubicin and a prodrug of mitomycin C | |
| KR102896612B1 (ko) | 방사선 및/또는 항암 치료 보조 요법으로 아데노신 디포스페이트 리보오스의 활용 | |
| George Zhu et al. | The effect of vincristine–polyanion complexes in STEALTH liposomes on pharmacokinetics, toxicity and anti tumor activity | |
| JP2021518443A5 (https=) | ||
| JP2018527402A (ja) | Ｔ−ｄｍ１難治性がん患者のｓｙｄ９８５処置 | |
| US7439234B2 (en) | Method for treating cancer patients undergoing chemotherapy | |
| WO2019023873A1 (zh) | 一种用于治疗造血系统增殖性疾病的纳米脂质微粒组合物及药用组合物 | |
| US8293274B2 (en) | Intestinal absorptive anti-tumor agent | |
| JP2004504346A (ja) | 骨転移の治療におけるリン酸エストラムスチンの使用 | |
| Velebny et al. | Toxocara canis in mice: effect of stabilised liposomes on the larvicidal efficacy of fenbendazole and albendazole | |
| TW202023568A (zh) | 用於治療癌症之組合療法 | |
| JPH03502924A (ja) | 高度に完全なリポソームおよびその製剤法と用途 | |
| EA004647B1 (ru) | Способы потенциации внутривенного эстрамустинфосфата | |
| CN118320103A (zh) | 一种药物组合物及其在制备抗肿瘤的药物中的应用 |